Personalized Bioactive Extract Generation System

Publication ID: 24-11857587_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Personalized Bioactive Extract Generation System,” Published Technical Disclosure No. 24-11857587_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857587_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,587.

Summary of the Inventive Concept

A next-generation system that leverages machine learning, genetic profiling, and cloud-based databases to generate personalized bioactive extracts tailored to individual health needs, revolutionizing the field of medicinal fungal species-based compositions.

Background and Problem Solved

The original patent's composition and methods, although innovative, are limited by their one-size-fits-all approach. The present inventive concept addresses this limitation by introducing a personalized approach, recognizing that individual genetic profiles and health risks require customized bioactive extracts for optimal efficacy.

Detailed Description of the Inventive Concept

The system comprises a bioactive extract generator, a machine learning module, and a cloud-based database. The generator produces a personalized bioactive extract based on an individual's genetic profile, analyzed by the machine learning module to identify specific health risks. The system selects a medicinal fungal species, ferments it, and recommends a customized treatment plan. The composition includes a bioactive extract from a genetically engineered medicinal fungal species, designed to produce a specific combination of bioactive compounds tailored to an individual's health needs. A wearable device and cloud-based database enable continuous monitoring and adjustment of the treatment plan.

Novelty and Inventive Step

The inventive concept's novelty lies in its integration of machine learning, genetic profiling, and cloud-based databases to generate personalized bioactive extracts. The inventive step resides in the system's ability to analyze individual health data and recommend customized treatment plans, overcoming the limitations of traditional, non-personalized compositions.

Alternative Embodiments and Variations

Alternative embodiments may include mobile applications for health data tracking, integration with electronic health records, or the use of other types of machine learning algorithms. Variations may involve different types of medicinal fungal species, genetic engineering techniques, or wearable devices.

Potential Commercial Applications and Market

The personalized bioactive extract generation system has vast commercial potential in the pharmaceutical, nutraceutical, and wellness industries, targeting individuals seeking tailored health solutions. The system's ability to provide customized treatment plans and continuous monitoring can disrupt traditional healthcare models, offering a new paradigm for personalized medicine.

CPC Classifications

SectionClassGroup
A A61 A61K36/074
A A61 A61K36/185
A A61 A61K2236/333

Original Patent Information

Patent NumberUS 11,857,587
TitleBioactive extract